Cargando…

Use of Direct-to-Consumer Telemedicine to Access Mental Health Services

BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohman, Jessica A., Martinez, Kathryn A., Anand, Amit, Rood, Mark, Martyn, Trejeeve, Rose, Susannah, Rothberg, Michael B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799413/
https://www.ncbi.nlm.nih.gov/pubmed/35091925
http://dx.doi.org/10.1007/s11606-021-07326-y
_version_ 1784642062975500288
author Hohman, Jessica A.
Martinez, Kathryn A.
Anand, Amit
Rood, Mark
Martyn, Trejeeve
Rose, Susannah
Rothberg, Michael B.
author_facet Hohman, Jessica A.
Martinez, Kathryn A.
Anand, Amit
Rood, Mark
Martyn, Trejeeve
Rose, Susannah
Rothberg, Michael B.
author_sort Hohman, Jessica A.
collection PubMed
description BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic use for mental healthcare. OBJECTIVE: To characterize patients, providers, and their use of a large nationwide DTC telemedicine platform for mental healthcare. DESIGN: Retrospective cross-sectional study. SETTING: Mental health encounters conducted on the American Well DTC telemedicine platform from 2016 to 2018. PARTICIPANTS: Patients and physicians. MAIN MEASURES: Patient measures included demographics, insurance report, and number of visits. Provider characteristics included specialty, region, and number of encounters. Encounter measures included wait time, visit length and timing, out-of-pocket payment, coupon use, prescription outcome, referral receipt, where care otherwise would have been sought, and patient satisfaction. Factors associated with five-star physician ratings and prescription receipt were assessed using logistic regression. KEY RESULTS: We analyzed 19,270 mental health encounters between 6708 patients and 1045 providers. Visits were most frequently for anxiety (39.1%) or depression (32.5%), with high satisfaction (4.9/5) across conditions. Patients had a median 2.0 visits for psychiatry (IQR 1.0–3.0) and therapy (IQR 1.0–5.0), compared to 1.0 visit (IQR 1.0–1.0) for urgent care. High satisfaction was positively correlated with prescription receipt (OR 1.89, 95% CI 1.54–2.32) and after-hours timing (aOR 1.18, 95% CI 1.02–1.36). Prescription rates ranged from 79.6% for depression to 32.2% for substance use disorders. Prescription receipt was associated with increased visit frequency (aOR 1.95, 95% CI 1.57–2.42 for ≥ 3 visits). CONCLUSIONS: As the burden of psychiatric disease grows, DTC telemedicine offers one solution for extending access to mental healthcare. While most encounters were one-off, evidence of some continuity in psychiatry and therapy visits—as well as overall high patient satisfaction—suggests potential for broader DTC telemental health use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07326-y.
format Online
Article
Text
id pubmed-8799413
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-87994132022-01-31 Use of Direct-to-Consumer Telemedicine to Access Mental Health Services Hohman, Jessica A. Martinez, Kathryn A. Anand, Amit Rood, Mark Martyn, Trejeeve Rose, Susannah Rothberg, Michael B. J Gen Intern Med Original Research BACKGROUND: The coronavirus disease 2019 pandemic has contributed to growing demand for mental health services, but patients face significant barriers to accessing care. Direct-to-consumer(DTC) telemedicine has been proposed as one way to increase access, yet little is known about its pre-pandemic use for mental healthcare. OBJECTIVE: To characterize patients, providers, and their use of a large nationwide DTC telemedicine platform for mental healthcare. DESIGN: Retrospective cross-sectional study. SETTING: Mental health encounters conducted on the American Well DTC telemedicine platform from 2016 to 2018. PARTICIPANTS: Patients and physicians. MAIN MEASURES: Patient measures included demographics, insurance report, and number of visits. Provider characteristics included specialty, region, and number of encounters. Encounter measures included wait time, visit length and timing, out-of-pocket payment, coupon use, prescription outcome, referral receipt, where care otherwise would have been sought, and patient satisfaction. Factors associated with five-star physician ratings and prescription receipt were assessed using logistic regression. KEY RESULTS: We analyzed 19,270 mental health encounters between 6708 patients and 1045 providers. Visits were most frequently for anxiety (39.1%) or depression (32.5%), with high satisfaction (4.9/5) across conditions. Patients had a median 2.0 visits for psychiatry (IQR 1.0–3.0) and therapy (IQR 1.0–5.0), compared to 1.0 visit (IQR 1.0–1.0) for urgent care. High satisfaction was positively correlated with prescription receipt (OR 1.89, 95% CI 1.54–2.32) and after-hours timing (aOR 1.18, 95% CI 1.02–1.36). Prescription rates ranged from 79.6% for depression to 32.2% for substance use disorders. Prescription receipt was associated with increased visit frequency (aOR 1.95, 95% CI 1.57–2.42 for ≥ 3 visits). CONCLUSIONS: As the burden of psychiatric disease grows, DTC telemedicine offers one solution for extending access to mental healthcare. While most encounters were one-off, evidence of some continuity in psychiatry and therapy visits—as well as overall high patient satisfaction—suggests potential for broader DTC telemental health use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11606-021-07326-y. Springer International Publishing 2022-01-29 2022-08 /pmc/articles/PMC8799413/ /pubmed/35091925 http://dx.doi.org/10.1007/s11606-021-07326-y Text en © The Author(s) under exclusive licence to Society of General Internal Medicine 2022
spellingShingle Original Research
Hohman, Jessica A.
Martinez, Kathryn A.
Anand, Amit
Rood, Mark
Martyn, Trejeeve
Rose, Susannah
Rothberg, Michael B.
Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title_full Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title_fullStr Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title_full_unstemmed Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title_short Use of Direct-to-Consumer Telemedicine to Access Mental Health Services
title_sort use of direct-to-consumer telemedicine to access mental health services
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799413/
https://www.ncbi.nlm.nih.gov/pubmed/35091925
http://dx.doi.org/10.1007/s11606-021-07326-y
work_keys_str_mv AT hohmanjessicaa useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT martinezkathryna useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT anandamit useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT roodmark useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT martyntrejeeve useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT rosesusannah useofdirecttoconsumertelemedicinetoaccessmentalhealthservices
AT rothbergmichaelb useofdirecttoconsumertelemedicinetoaccessmentalhealthservices